2 weeks Medtronic (NYSE:MDT) Rating Increased to Outperform at Royal Bank of CanadaMarketBeat
Royal Bank of Canada upgraded shares of Medtronic from a “sector perform” rating to an “outperform” rating and boosted their target price for the company from $98.00 to $105.00 in a report on Thursday.
Canada · Medtronic (MDT) · NYSE · Royal Bank of Canada
X